Share Facebook Twitter Email A prospective randomized phase 2 trial of 233 patients with treatment-refractory depression demonstrates a significant improvement at 3 weeks with a single 25 mg dose of psilocybin. Citation(s) Goodwin, N Engl J Med 2022